KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Repurchased
Ratios

Resmed (RMD) Long-Term Debt Issuances (2016 - 2023)

Historic Long-Term Debt Issuances for Resmed (RMD) over the last 13 years, with Q3 2023 value amounting to $105.0 million.

  • Resmed's Long-Term Debt Issuances rose 11000.0% to $105.0 million in Q3 2023 from the same period last year, while for Jun 2024 it was $105.0 million, marking a year-over-year decrease of 9018.69%. This contributed to the annual value of $105.0 million for FY2024, which is 9018.69% down from last year.
  • Resmed's Long-Term Debt Issuances amounted to $105.0 million in Q3 2023, which was up 11000.0% from $1.0 billion recorded in Q4 2022.
  • In the past 5 years, Resmed's Long-Term Debt Issuances ranged from a high of $1.0 billion in Q4 2022 and a low of $10.0 million during Q4 2021
  • Its 5-year average for Long-Term Debt Issuances is $226.5 million, with a median of $139.0 million in 2021.
  • Its Long-Term Debt Issuances has fluctuated over the past 5 years, first plummeted by 9026.55% in 2020, then soared by 1010000.0% in 2022.
  • Over the past 5 years, Resmed's Long-Term Debt Issuances (Quarter) stood at $165.0 million in 2019, then tumbled by 66.67% to $55.0 million in 2020, then plummeted by 81.82% to $10.0 million in 2021, then soared by 10100.0% to $1.0 billion in 2022, then tumbled by 89.71% to $105.0 million in 2023.
  • Its Long-Term Debt Issuances stands at $105.0 million for Q3 2023, versus $1.0 billion for Q4 2022 and $50.0 million for Q3 2022.